Copyright
©The Author(s) 2021.
World J Gastrointest Endosc. Dec 16, 2021; 13(12): 659-672
Published online Dec 16, 2021. doi: 10.4253/wjge.v13.i12.659
Published online Dec 16, 2021. doi: 10.4253/wjge.v13.i12.659
High volume one-day (n = 482) | High volume split dose (n = 389) | P value1 | Low volume one-day (n = 583) | Low volume split dose (n = 361) | P value1 | |
Global tolerance, VAS score2, median (interquartile range) | 7 (5-8) | 7 (5-9) | 0.0063 | 7 (5-9) | 7 (5-9) | 0.033 |
Incomplete preparation | 37 (7.9) | 30 (7.9) | 0.994 | 31 (5.5) | 18 (5.2) | 0.840 |
Any symptom during preparation | 211 (43.8) | 158 (40.6) | 0.384 | 324 (55.6) | 167 (46.3) | 0.0053 |
Bloating | 103 (21.4) | 80 (20.6) | 0.772 | 126 (21.6) | 54 (14.9) | 0.0113 |
Nausea | 112 (23.2) | 75 (19.3) | 0.158 | 196 (33.6) | 97 (26.9) | 0.0293 |
Vomiting | 33 (6.9) | 22 (5.7) | 0.473 | 73 (12.5) | 46 (12.7) | 0.921 |
Abdominal pain | 54 (11.2) | 50 (12.9) | 0.455 | 105 (18.0) | 72 (19.9) | 0.459 |
- Citation: Occhipinti V, Soriani P, Bagolini F, Milani V, Rondonotti E, Annunziata ML, Cavallaro F, Vavassori S, Vecchi M, Pastorelli L, Tontini GE. Efficacy and tolerability of high and low-volume bowel preparation compared: A real-life single-blinded large-population study. World J Gastrointest Endosc 2021; 13(12): 659-672
- URL: https://www.wjgnet.com/1948-5190/full/v13/i12/659.htm
- DOI: https://dx.doi.org/10.4253/wjge.v13.i12.659